Here are the 424B prospectus supplements from BlackRock Capital Allocation Term Trust (BCAT) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 424B covers the supplement that carries the terms of a priced offering, so if you follow BCAT and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full BCAT filings page.
BlackRock Capital Allocation Term Trust (BCAT) is issuing 106,276,002 transferable subscription rights for 21,255,200 common shares of beneficial interest. Holders of record on September 25, 2026 receive one right per common share; five rights permit purchase of one new share, while holders with fewer than five record-date shares may subscribe for one. The estimated subscription price is $13.65 per share. The final price is based on 95% of the average sales price on the expiration date and four prior trading days, with adjustments to $0.01 below NAV if that formula price is at or above NAV, or to 98.5% of NAV if it is below 98.5% of NAV. The rights expire October 21, 2026, unless extended.
The Trust estimates net proceeds of $290,133,480.00 if all offered shares are sold; the Advisor is expected to bear approximately $517,000 in offering expenses. The Trust expects to invest proceeds within approximately three months of receipt, subject to possible delays if suitable investments are unavailable or market conditions interfere. Its full-subscription illustration estimates a 0.27% NAV-per-share reduction using $13.86 NAV and a $13.65 subscription price. New shares will not receive the October 30, 2026 distribution but are eligible for the monthly distribution expected November 30, 2026.